QTTB Q32 Bio15.83+0.78 (+5.2%)
QTTB Q32 Bio17.73-0.73 (-4.0%)
QTTB Q32 Bio20.50-0.88 (-4.1%)
QTTB Q32 Bio20.21+9.00 (+80.3%)
After Hours Gainer
QTTB Q32 Bio11.21-1.38-11.0%
After Hours:14.55+3.34 (+29.8%)
Q32 Bio to Report 36-Week Topline Results from Part B of SIGNAL-AA Clinical Trial of Bempikibart in Alopecia Areata on July 13, 2026
PRNewswireFri, 10-Jul 4:05 PM
After Hours:13.33+2.12 (+18.9%)